Exorenal
xKidney – Novel Portable & Home Hemodialysis System
Chronic kidney failure patients are steeply increasing worldwide. In-center hemodialysis (HD) has become the standard treatment, but this has raised many problems. Most patients suffer from harsh dietary restrictions and severe complications, resulting in an unacceptably high rate of mortality: ~50% over 5 years. Due to the dialysis schedules (3 times a week), travel arrangements and participation in social activities…Read More
Longeviti
Pioneering Innovative Solutions for Complex Brain Surgery
Longeviti’s mission is to develop innovative solutions for complex brain surgery that return patients to anatomical normalcy.
Renalert
Real Time Renal Monitoring
Real time renal monitoring device for surgical and ICU settings. Acute Kidney Injury (AKI) carries a higher associated yearly mortality rate than breast cancer, prostate cancer, heart failure, and diabetes combined. Renalert LLC is developing the real-time monitoring Renalert System to detect Acute Kidney Stress and early declines in kidney function before injury occurs.
EyeDea
Alleviating the global burden of corneal blindness through innovative solutions in eye banking and corneal transplantation
Eyedea Medical is an early-stage, women-owned, ophthalmic medical device company working to reduce the burden of corneal blindness globally through development of novel medical devices to improve outcomes and access to vision-restoring corneal procedures. Our first product, DescePrep, is a DMEK preparation device that standardizes and improves the efficiency.
Novel Microdevices
Manufacturing Innovative Diagnostic Products for Enhancing Patient Healthcare
Novel Microdevices is commercializing Novel Dx, a proprietary and best-in-class Point-of-Care (POC) rapid molecular diagnostics system that is designed to be CLIA-waived. The Novel Dx system includes an ultra-portable instrument and test-specific consumable cartridges that can be produced for a wide range of high-volume molecular diagnostic assay applications. The company is focusing on the $31 Billion Infectious Diseases Diagnostics Market with tests in development for multiple respiratory and sexually transmitted infections.
Lifesprout
Revolutionary Products for Tissue Replacement and Regeneration
LifeSprout, Inc. is a privately held company developing revolutionary products for aesthetic and regenerative medicine. The company’s Regenerative Matrix platform leverages advances in materials science to create products that look and feel like the body’s own tissues. LifeSprout is turning this technology into a suite of products for the millions of patients with tissue losses from aging, cancer, metabolic disease, and orphan indications. The company’s lead product Lumina™ is a breakthrough family of aesthetic fillers enabling immediate, natural restoration with biostimulatory effects. LifeSprout’s next generation cell therapy products use the power of the platform to promote true tissue regeneration.
Coaptech
Ultrasound Gastrostomy is Here
CoapTech seeks to bring a series of breakthrough medical devices to worldwide markets, leveraging a patented, disruptive technology called Coaptive Ultrasound which is owned by the company. CoapTech devices will reduce health care costs, and improve safety, quality, patient experience, and access to services around the globe.
Vixiar
Point of Care, Non-invasive, Cost Effective Monitoring for Heart Failure
Vixiar Medical has developed a non-invasive, hand-held device and software platform, for assessing congestion to detect worsening heart failure. The Company’s Indicor™ device is for point-of-care use in hospitals, physician’s offices and patient homes and is an alternative to less accurate, more expensive, and invasive approaches. Indicor is the only true point-of-care, and remote monitoring device for detecting changes in intrathoracic fluid volume. The test takes under 3 minutes to perform and is spun out of John’s Hopkins